Cargando…

Prioritising COVID-19 vaccination in changing social and epidemiological landscapes: a mathematical modelling study

BACKGROUND: During the COVID-19 pandemic, authorities must decide which groups to prioritise for vaccination in a shifting social–epidemiological landscape in which the success of large-scale non-pharmaceutical interventions requires broad social acceptance. We aimed to compare projected COVID-19 mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Jentsch, Peter C, Anand, Madhur, Bauch, Chris T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012029/
https://www.ncbi.nlm.nih.gov/pubmed/33811817
http://dx.doi.org/10.1016/S1473-3099(21)00057-8
_version_ 1783673301488369664
author Jentsch, Peter C
Anand, Madhur
Bauch, Chris T
author_facet Jentsch, Peter C
Anand, Madhur
Bauch, Chris T
author_sort Jentsch, Peter C
collection PubMed
description BACKGROUND: During the COVID-19 pandemic, authorities must decide which groups to prioritise for vaccination in a shifting social–epidemiological landscape in which the success of large-scale non-pharmaceutical interventions requires broad social acceptance. We aimed to compare projected COVID-19 mortality under four different strategies for the prioritisation of SARS-CoV-2 vaccines. METHODS: We developed a coupled social–epidemiological model of SARS-CoV-2 transmission in which social and epidemiological dynamics interact with one another. We modelled how population adherence to non-pharmaceutical interventions responds to case incidence. In the model, schools and workplaces are also closed and reopened on the basis of reported cases. The model was parameterised with data on COVID-19 cases and mortality, SARS-CoV-2 seroprevalence, population mobility, and demography from Ontario, Canada (population 14·5 million). Disease progression parameters came from the SARS-CoV-2 epidemiological literature. We assumed a vaccine with 75% efficacy against disease and transmissibility. We compared vaccinating those aged 60 years and older first (oldest-first strategy), vaccinating those younger than 20 years first (youngest-first strategy), vaccinating uniformly by age (uniform strategy), and a novel contact-based strategy. The latter three strategies interrupt transmission, whereas the first targets a vulnerable group to reduce disease. Vaccination rates ranged from 0·5% to 5% of the population per week, beginning on either Jan 1 or Sept 1, 2021. FINDINGS: Case notifications, non-pharmaceutical intervention adherence, and lockdown undergo successive waves that interact with the timing of the vaccine programme to determine the relative effectiveness of the four strategies. Transmission-interrupting strategies become relatively more effective with time as herd immunity builds. The model predicts that, in the absence of vaccination, 72 000 deaths (95% credible interval 40 000–122 000) would occur in Ontario from Jan 1, 2021, to March 14, 2025, and at a vaccination rate of 1·5% of the population per week, the oldest-first strategy would reduce COVID-19 mortality by 90·8% on average (followed by 89·5% in the uniform, 88·9% in the contact-based, and 88·2% in the youngest-first strategies). 60 000 deaths (31 000–108 000) would occur from Sept 1, 2021, to March 14, 2025, in the absence of vaccination, and the contact-based strategy would reduce COVID-19 mortality by 92·6% on average (followed by 92·1% in the uniform, 91·0% in the oldest-first, and 88·3% in the youngest-first strategies) at a vaccination rate of 1·5% of the population per week. INTERPRETATION: The most effective vaccination strategy for reducing mortality due to COVID-19 depends on the time course of the pandemic in the population. For later vaccination start dates, use of SARS-CoV-2 vaccines to interrupt transmission might prevent more deaths than prioritising vulnerable age groups. FUNDING: Ontario Ministry of Colleges and Universities.
format Online
Article
Text
id pubmed-8012029
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-80120292021-04-01 Prioritising COVID-19 vaccination in changing social and epidemiological landscapes: a mathematical modelling study Jentsch, Peter C Anand, Madhur Bauch, Chris T Lancet Infect Dis Articles BACKGROUND: During the COVID-19 pandemic, authorities must decide which groups to prioritise for vaccination in a shifting social–epidemiological landscape in which the success of large-scale non-pharmaceutical interventions requires broad social acceptance. We aimed to compare projected COVID-19 mortality under four different strategies for the prioritisation of SARS-CoV-2 vaccines. METHODS: We developed a coupled social–epidemiological model of SARS-CoV-2 transmission in which social and epidemiological dynamics interact with one another. We modelled how population adherence to non-pharmaceutical interventions responds to case incidence. In the model, schools and workplaces are also closed and reopened on the basis of reported cases. The model was parameterised with data on COVID-19 cases and mortality, SARS-CoV-2 seroprevalence, population mobility, and demography from Ontario, Canada (population 14·5 million). Disease progression parameters came from the SARS-CoV-2 epidemiological literature. We assumed a vaccine with 75% efficacy against disease and transmissibility. We compared vaccinating those aged 60 years and older first (oldest-first strategy), vaccinating those younger than 20 years first (youngest-first strategy), vaccinating uniformly by age (uniform strategy), and a novel contact-based strategy. The latter three strategies interrupt transmission, whereas the first targets a vulnerable group to reduce disease. Vaccination rates ranged from 0·5% to 5% of the population per week, beginning on either Jan 1 or Sept 1, 2021. FINDINGS: Case notifications, non-pharmaceutical intervention adherence, and lockdown undergo successive waves that interact with the timing of the vaccine programme to determine the relative effectiveness of the four strategies. Transmission-interrupting strategies become relatively more effective with time as herd immunity builds. The model predicts that, in the absence of vaccination, 72 000 deaths (95% credible interval 40 000–122 000) would occur in Ontario from Jan 1, 2021, to March 14, 2025, and at a vaccination rate of 1·5% of the population per week, the oldest-first strategy would reduce COVID-19 mortality by 90·8% on average (followed by 89·5% in the uniform, 88·9% in the contact-based, and 88·2% in the youngest-first strategies). 60 000 deaths (31 000–108 000) would occur from Sept 1, 2021, to March 14, 2025, in the absence of vaccination, and the contact-based strategy would reduce COVID-19 mortality by 92·6% on average (followed by 92·1% in the uniform, 91·0% in the oldest-first, and 88·3% in the youngest-first strategies) at a vaccination rate of 1·5% of the population per week. INTERPRETATION: The most effective vaccination strategy for reducing mortality due to COVID-19 depends on the time course of the pandemic in the population. For later vaccination start dates, use of SARS-CoV-2 vaccines to interrupt transmission might prevent more deaths than prioritising vulnerable age groups. FUNDING: Ontario Ministry of Colleges and Universities. Elsevier Ltd. 2021-08 2021-03-31 /pmc/articles/PMC8012029/ /pubmed/33811817 http://dx.doi.org/10.1016/S1473-3099(21)00057-8 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Articles
Jentsch, Peter C
Anand, Madhur
Bauch, Chris T
Prioritising COVID-19 vaccination in changing social and epidemiological landscapes: a mathematical modelling study
title Prioritising COVID-19 vaccination in changing social and epidemiological landscapes: a mathematical modelling study
title_full Prioritising COVID-19 vaccination in changing social and epidemiological landscapes: a mathematical modelling study
title_fullStr Prioritising COVID-19 vaccination in changing social and epidemiological landscapes: a mathematical modelling study
title_full_unstemmed Prioritising COVID-19 vaccination in changing social and epidemiological landscapes: a mathematical modelling study
title_short Prioritising COVID-19 vaccination in changing social and epidemiological landscapes: a mathematical modelling study
title_sort prioritising covid-19 vaccination in changing social and epidemiological landscapes: a mathematical modelling study
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012029/
https://www.ncbi.nlm.nih.gov/pubmed/33811817
http://dx.doi.org/10.1016/S1473-3099(21)00057-8
work_keys_str_mv AT jentschpeterc prioritisingcovid19vaccinationinchangingsocialandepidemiologicallandscapesamathematicalmodellingstudy
AT anandmadhur prioritisingcovid19vaccinationinchangingsocialandepidemiologicallandscapesamathematicalmodellingstudy
AT bauchchrist prioritisingcovid19vaccinationinchangingsocialandepidemiologicallandscapesamathematicalmodellingstudy